2018 American Transplant Congress

June 2-6, 2018 in Seattle, WA

View by Title View Sessions

View by Date

Sunday, June 3, 2018

6:00pm-7:00pm: Impact of Sleep Apnea Syndrome on Late Graft Dysfunction

A. Afzal,¹ K. Tecson,² A. Jamil,³ A. Wazir,¹ J. Felius,³ H. Qin,³ P. Garcha,¹ S. Carey,¹ S. Hall.¹

Poster Session B: Heart and VADs: All Topics • Hall 4EF

6:00pm-7:00pm: Improved Mouse Renal Transplantation Model Mimicking Clinical Antibody Mediated Rejection

D. Zhao,¹ T. Liao,¹ S. Li,¹ J. Zhou,² F. Han,¹ Y. Dong,³ Q. Sun.¹

Poster Session B: Acute and Chronic Graft Injury • Hall 4EF

6:00pm-7:00pm: Improving Participation in Non-A1/Non-A1B to B Deceased Donor Program Post Kidney Allocation System (KAS)- A Single Center Experience

H. Khamash, J. Adamski, R. Heilman, A. Mathur, A. Moss, A. Kumar, Q. Lu, K. Reddy.

Poster Session B: Kidney Deceased Donor Allocation • Hall 4EF

6:00pm-7:00pm: Incidence of Epstein Barr Virus (EBV) DNAemia in EBV-Seronegative Solid Organ Transplant (SOT) Recipients with EBV-Seropositive Donors

C. Burton,¹ C. Mabilangan,² J. Preiksaitis.²

Poster Session B: PTLD/Malignancies: All Topics • Hall 4EF

6:00pm-7:00pm: Incidence of Pneumonitis in Heart Transplant Patients Started on a Proliferation Signal Inhibitor

R. Levine, J. Patel, M. Levine, M. Kittleson, E. Kransdorf, S. Dimbil, D. Geft, D. Chang, L. Czer, J. Kobashigawa.

Poster Session B: Heart and VADs: All Topics • Hall 4EF

6:00pm-7:00pm: Increased Length of Stay of the Donor Decreases Heart Transplant Recipient Survival

H. Copeland,¹ R. Talluri,² A. Panos,¹ R. Cochran,¹ L. Creswell,¹ D. Baran.³

Poster Session B: Heart and VADs: All Topics • Hall 4EF

6:00pm-7:00pm: Increasing Obesity and Diabetes Prevalence in the United States End-Stage Renal Disease Population

B. Shelton,¹ D. McWilliams,¹ P. MacLennan,¹ R. Reed,¹ M. Mustian,¹ D. Sawinski,² J. Locke.

Poster Session B: Non-Organ Specific: Economics, Public Policy, Allocation, Ethics • Hall 4EF

6:00pm-7:00pm: Increasing Obesity Prevalence in the United States Pediatric End-Stage Renal Disease Population

B. Shelton,¹ P. MacLennan,¹ R. Reed,¹ M. Mustian,¹ D. McWilliams,¹ D. Sawinski,² J. Locke.¹

Poster Session B: Kidney: Pediatrics • Hall 4EF

6:00pm-7:00pm: Individualized Immunosuppression through Risk-Stratification in Renal Transplantation Preserves Excellent Outcomes at Three Years

J. Dann, A. Agarwal, M. Bradley, J. Geyston, W. Ally.

Poster Session B: Kidney Immunosuppression: Induction Therapy • Hall 4EF

6:00pm-7:00pm: Induction Agents and Post-Transplant Malignancies in Kidney Transplants: An Examination of Outcomes at a Large Volume Center over 20 Years

D. Livingston-Rosanoff, X. Wang, G. Leverson, D. Kaufman, D. Foley.

Poster Session B: PTLD/Malignancies: All Topics • Hall 4EF